| Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype M Balic, H Lin, L Young, D Hawes, A Giuliano, G McNamara, RH Datar, ... Clinical cancer research 12 (19), 5615-5621, 2006 | 867 | 2006 |
| Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells S Zheng, H Lin, JQ Liu, M Balic, R Datar, RJ Cote, YC Tai Journal of chromatography A 1162 (2), 154-161, 2007 | 772 | 2007 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial M Gnant, G Pfeiler, PC Dubsky, M Hubalek, R Greil, R Jakesz, V Wette, ... The Lancet 386 (9992), 433-443, 2015 | 579 | 2015 |
| Portable filter-based microdevice for detection and characterization of circulating tumor cells HK Lin, S Zheng, AJ Williams, M Balic, S Groshen, HI Scher, M Fleisher, ... Clinical Cancer Research 16 (20), 5011-5018, 2010 | 543 | 2010 |
| Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal … M Gnant, M Filipits, R Greil, H Stoeger, M Rudas, Z Bago-Horvath, ... Annals of oncology 25 (2), 339-345, 2014 | 447 | 2014 |
| Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis … M Gnant, B Mlineritsch, H Stoeger, G Luschin-Ebengreuth, M Knauer, ... Annals of Oncology 26 (2), 313-320, 2015 | 338 | 2015 |
| St. Gallen/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment M Balic, C Thomssen, R Würstlein, M Gnant, N Harbeck Breast Care 14 (2), 103-110, 2019 | 219 | 2019 |
| Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo … M Gnant, G Pfeiler, GG Steger, D Egle, R Greil, F Fitzal, V Wette, M Balic, ... The Lancet Oncology 20 (3), 339-351, 2019 | 210 | 2019 |
| Comparison of two methods for enumerating circulating tumor cells in carcinoma patients M Balic, N Dandachi, G Hofmann, H Samonigg, H Loibner, A Obwaller, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2005 | 190 | 2005 |
| Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial F Fitzal, V Bjelic-Radisic, M Knauer, G Steger, M Hubalek, M Balic, ... Annals of surgery 269 (6), 1163-1169, 2019 | 158 | 2019 |
| Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine … M Gnant, I Sestak, M Filipits, M Dowsett, M Balic, E Lopez-Knowles, ... Annals of Oncology 26 (8), 1685-1691, 2015 | 137 | 2015 |
| St. Gallen/Vienna 2021: a brief summary of the consensus discussion on customizing therapies for women with early breast cancer C Thomssen, M Balic, N Harbeck, M Gnant Breast Care 16 (2), 135-143, 2021 | 133 | 2021 |
| Disseminated and circulating tumor cells: Role in effective cancer management H Lin, M Balic, S Zheng, R Datar, RJ Cote Critical reviews in oncology/hematology 77 (1), 1-11, 2011 | 121 | 2011 |
| Circulating tumor cells: from bench to bedside M Balic, A Williams, H Lin, R Datar, RJ Cote Annual review of medicine 64, 31-44, 2013 | 116 | 2013 |
| Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors M Pichler, M Balic, E Stadelmeyer, C Ausch, M Wild, C Guelly, ... The Journal of Molecular Diagnostics 11 (2), 140-147, 2009 | 112 | 2009 |
| Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer M Gnant, F Fitzal, G Rinnerthaler, GG Steger, S Greil-Ressler, M Balic, ... New England Journal of Medicine 385 (5), 395-405, 2021 | 111 | 2021 |
| Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles M Birkhahn, AP Mitra, AJ Williams, G Lam, W Ye, RH Datar, M Balic, ... European urology 57 (1), 12-20, 2010 | 101 | 2010 |
| Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative P Aftimos, M Oliveira, A Irrthum, D Fumagalli, C Sotiriou, EN Gal-Yam, ... Cancer discovery 11 (11), 2796-2811, 2021 | 92 | 2021 |
| The role of microRNAs in breast cancer stem cells D Schwarzenbacher, M Balic, M Pichler International journal of molecular sciences 14 (7), 14712-14723, 2013 | 89 | 2013 |
| Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry SP Gampenrieder, G Rinnerthaler, C Tinchon, A Petzer, M Balic, S Heibl, ... Breast Cancer Research 23 (1), 112, 2021 | 88 | 2021 |
